Internal Medicine · Pittsburgh, PA
NPI
1609060755
Since 2007
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
5150 Centre Ave
Pittsburgh, PA, 15232
Phone (412) 648-6413
Groups this clinician bills Medicare through
Medicare paid, 2024
$26K
263 services
Medicare patients, 2024
101
Average age 72
Drug cost, 2024
$1.2M
377 prescriptions
Company payments, 2025
$7,639
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Liza C Villaruz was code 99215 (office e&m - established), 146 times for 56 patients. In total Liza C Villaruz billed 263 services in 10 codes, and Medicare paid $26K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-05-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 146 | 56 | $105.41 | $15K |
| 99233 Hospital E&M - Subsequent | Facility | 43 | 19 | $83.99 | $3,611 |
| 99205 Office E&M - New | Office | 25 | 25 | $133.07 | $3,327 |
| 99238 Hospital Discharge Management | Facility | 12 | 12 | $61.00 | $732 |
By year: 2022 $28K for 271 services; 2023 $18K for 174 services; 2024 $26K for 263 services.
Medicare prescription drug claims, 2024
In 2024, the drug Liza C Villaruz prescribed most often to Medicare patients was Ondansetron Hcl, with 52 prescriptions and refills. In total Liza C Villaruz wrote 377 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ondansetron Hcl Generic | 52 | 54 | 35 | $607 |
| Prochlorperazine Maleate Generic | 40 | 40 | 32 | $1,567 |
| Lorbrena Lorlatinib | 23 | 23 | Under 11 | $501K |
| Levothyroxine Sodium Generic | 20 | 24 | Under 11 | $122 |
| Oxycodone Hcl Generic | 16 | 16 | Under 11 | $169 |
| Prednisone Generic | 15 | 15 | Under 11 | $42.69 |
| Potassium Chloride Generic | 14 | 14 | Under 11 | $86.43 |
| Dexamethasone Generic | 14 | 16 | 11 | $214 |
| Olanzapine Generic | 13 | 21 | Under 11 | $201 |
| Tagrisso Osimertinib Mesylate | 12 | 12 | Under 11 | $203K |
| Gilotrif Afatinib Dimaleate | 11 | 11 | Under 11 | $131K |
Brand drugs: 80 claims; generic drugs: 297 claims; opioid claims: 18.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Liza C Villaruz $7,639 ($6,909 in general payments such as food, travel and fees and $731 for research) from 24 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $1,614.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $1,614 |
| Eli Lilly and Company LLY | 2 | $1,538 |
| Pfizer Inc. PFE | 1 | $1,440 |
| Amgen Inc. AMGN | 2 | $1,109 |
| Regeneron Pharmaceuticals, Inc. REGN | 2 | $731 |
| Abbvie Inc. ABBV | 1 | $675 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $156 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $137 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $129 |
| Daiichi Sankyo Inc. 4568.T | 2 | $105 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.